The recent release of the updated WHO guidelines on cervical cancer screening and treatment represent the beginning of a transition toward a more effective global effort to eliminate this preventable disease by emphasizing HPV testing as the preferred method of screening. GIAHC and partners agree that funders of cervical cancer prevention programs in low-resource settings must begin to communicate when and how their funding policies will prioritize the shift to HPV testing in order to facilitate this important transition at the country level. On these lines of advocacy effort, letters were sent to leadership at PEPFAR, USAID, and the Global Fund acknowledging their guidance in the creation of the new guidelines and calling for clear timelines in which to implement HPV testing in their own funding portfolios. Click here to read the letters.
In Rwanda, 75% of women with cervical cancer don’t survive. The “One Egg-A-Day” initiative provides essential nutrition to those in treatment. Help us support these women—donate today.
GIAHC is proud to have been a part of the launch of the Mysore Consortium Against Cervical Cancer (MCACC) during the week of the centennial celebration of Mysore Medical College (Dr. Krishnan’s alma mater).
GIAHC is deeply honored to be a part of the “Quad Cancer Moonshot team,” collaborating with our partners to take bold action against #cervicalcancer in the Asia Pacific region. Together, we are committed to eliminating this disease for a healthier future.
Women in Asia are diagnosed with cervical cancer at a disproportionately higher rate than the global average. Despite early diagnosis leading to more effective treatment, many factors in the region prevent women from receiving the care that they need, and the consequences are severe, affecting not only women as individuals, but society at large.
It has been a great honor to be a part of President Biden’s Cancer Moonshot delegation to India and to participate in the US-India Cancer Dialogue Initiative.
GIAHC is excited to announce its partnership with CAPED India. Together, they will raise awareness about HPV vaccination among parents in India and develop an educational series for healthcare providers on cervical cancer screening and early treatment.
GIAHC is excited to announce its partnership with CAPED India. Together, they will raise awareness about HPV vaccination among parents in India and develop an educational series for healthcare providers on cervical cancer screening and early treatment.
The report details a campaign by GIAHC and PHRII on March 4th, International HPV Awareness Day, to boost HPV awareness in Mysuru. It focused on educating young adults and healthcare trainees, supporting WHO’s cervical cancer elimination efforts, and planning future prevention strategies.
On March 4th, GIAHC and PHRII in Mysore, India, will begin a week of HPV awareness events, highlighting the importance of vaccination and screening, culminating in a screening camp on International Women’s Day, March 8th.
GIAHC, in collaboration with Vaccine Ambassadors, is spearheading a fundraising initiative to donate 6,000 HPV vaccine doses to Suriname.